Skip to content
healthcare.dev
Get a free key

FLULAVAL 2026/2027

NDC 19515-822, influenza virus vaccine, suspension, from ID Biomedical Corporation of Quebec.

Product NDC
19515-822
Status
Listed
Labeler
ID Biomedical Corporation of Quebec
Dosage form
SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125163
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/19515-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR 278 (H1N1) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN 049A (H3N2) ANTIGEN (UV, FORMALDEHYDE INACTIVATED)15 ug/.5mL
  • INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (UV, FORMALDEHYDE INACTIVATED)15 ug/.5mL
Package NDCNDC-11Package
19515-822-521951508225210 SYRINGE in 1 CARTON (19515-822-52) / .5 mL in 1 SYRINGE (19515-822-41)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 19515-822 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/19515-822 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 19515-822. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.